4-(4-BROMOPHENYL)-4-(METHOXYMETHOXY)CYCLOHEXANONE, 90.0%, 250mg

4-Amino-3,5-dinitropyridine, 95.0%, 5g

2-(3-pyrrolidinyl)-2-propanol hydrochloride, 95.0%, 100mg

2-Cyclopropylisonicotinic acid, 95.0%, 5g

N-(Phenylthio)phthalimide>98.0%(GC)(N)5g

3-Chloro-5,6,7,8-tetrahydroisoquinoline, 95.0%, 1g

6-Bromo-2,3-dichlorobenzaldehyde, 98%, 1g

N-(2,4-Dimethoxybenzyl)-2,5-difluoro-4-(hydroxymethyl)-N-(1,2,4-thiadiazol-5-yl)benzenesulfonamide, 97%, 25mg

1-Bromo-4-dodecylbenzene>90.0%(GC)25g

Thymidine, min. 99%, pa, 500 mg, glass packaging

tert-Butyl 2-oxo-6-azaspiro[3.5]nonane-6-carboxylate, 95.0%, 1g

4-Amino-2-nitropyridine, 95.0%, 100mg

9-Phenyl-3,6-bis[4-(1-phenylbenzimidazol-2-yl)phenyl]carbazole>98.0%(HPLC)1g